Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / PLA2G2A

PLA2G2A

Basics

Aliases:
This biomarker is also known as:
  • MOM1,
  • EC 3.1.1.4,
  • PLA2,
  • phosphatidylcholine 2-acylhydrolase 2A,
  • phospholipase A2, membrane associated,
  • RASF-A,
  • Phosphatidylcholine 2-acylhydrolase 2A,
  • sPLA2,
  • PLA2S,
  • non-pancreatic secretory phospholipase A2,
  • PLA2B,
  • phospholipase A2, group IIA (platelets, synovial fluid),
  • PLA2L,
  • Non-pancreatic secretory phospholipase A2,
  • NPS-PLA2,
  • group IIA phospholipase A2,
  • PLAS1,
  • GIIC sPLA2,
  • Group IIA phospholipase A2,

View in BioMuta

Description…

phospholipase A2, group IIA (platelets, synovial fluid)

Attributes

QA State: Under Review
Type: Gene
Short Name:
HGNC Name: PLA2G2A

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2016 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take on a date and location to be determined.